Therefore, the molecules identified by the screening procedure described here are interesting drug candidates, both as anti-cancer agents for TRF2 downregulation as confirmed in this study, and potentially as anti-aging agents by upregulating TRF2. This evidence concerns the gene TERF2 and cancer.